Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Airflow Effects on Upper Airway Muscles in OSA
NCT03506178Unknown
- Sponsor
- Beijing Tongren Hospital
- Start
- Sep 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of Mucinex Full Force Nasal Spray in obstructive sleep apnea (OSA) (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoints: Apnea-Hypopnea Index, Myoelectricity of genioglossus and 1 more. Status: unknown.
02
Drugs
Mucinex Full Force Nasal Spray
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT03506178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03506178.